View details for
The Dual Role of Type I Interferons in CAR-Based Therapies: An Overview of Recent Research Insights
The Dual Role of Type I Interferons in CAR-Based Therapies: An Overview of Recent Research Insights
Type I interferons (Type I IFNs or IFN-I) can both enhance and hinder the efficacy of CAR-T cell therapy, a transformative treatment for hematological cancers. While IFN-I have been shown to support antitumor immunity and bolster CAR-T cell function…